M. A. Ferreira

Prognostic Significance of p53 Protein Expression in Early Gastric Cancer

A. R. Gonçalves, A. J. Carneiro, I. Martins, 2011, Pathology & Oncology Research.

Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy.

M. A. Ferreira, E. Marchiori, C. Viégas, 2015, Brachytherapy.

Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized Trial.

M. A. Ferreira, M. Valadão, I. Small, 2022, Clinical colorectal cancer.

TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil.

M. A. Ferreira, N. Andreollo, L. F. Ribeiro Pinto, 2010, Mutation research.

Esophageal squamous cell carcinoma transcriptome reveals the effect of FOXM1 on patient outcome through novel PIK3R3 mediated activation of PI3K signaling pathway

D. Esposito, M. A. Moreira, H. Seuánez, 2018, Oncotarget.

The protein-protein interaction network of intestinal gastric cancer patients reveals hub proteins with potential prognostic value.

M. A. Ferreira, E. Abdelhay, P. Fernandes, 2021, Cancer biomarkers : section A of Disease markers.

IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma

Z. Herceg, M. A. Ferreira, S. Guaraldi, 2021, Frontiers in Oncology.

Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.

M. A. Ferreira, N. Andreollo, R. Albano, 2007, Carcinogenesis.

Pharyngocutaneous fistula as an alternative access route for inserting a percutaneous endoscopic gastrostomy tube in head and neck cancer patients

M. A. Ferreira, F. Dias, G. Mansur, 2017, Endoscopy International Open.